SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001193125-23-196128
Filing Date
2023-07-27
Accepted
2023-07-27 16:21:56
Documents
5
Period of Report
2023-07-27

Document Format Files

Seq Description Document Type Size
1 6-K d469394d6k.htm 6-K 13745
2 EX-99.1 d469394dex991.htm EX-99.1 32514
3 GRAPHIC g469394dsp005a.jpg GRAPHIC 745
4 GRAPHIC g469394dsp005b.jpg GRAPHIC 681
5 GRAPHIC g469394g0727225240732.jpg GRAPHIC 2896
  Complete submission text file 0001193125-23-196128.txt   53920
Mailing Address 60 AVENUE ROCKEFELLER BATIMENT ADENINE LYON I0 69008
Business Address 60 AVENUE ROCKEFELLER BATIMENT ADENINE LYON I0 69008 011-33-4-78-74-44-38
PHAXIAM Therapeutics S.A. (Filer) CIK: 0001624422 (see all company filings)

IRS No.: 000000000 | State of Incorp.: I0 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-38281 | Film No.: 231118723
SIC: 2836 Biological Products, (No Diagnostic Substances)